<DOC>
	<DOCNO>NCT00625248</DOCNO>
	<brief_summary>This study evaluate bleeding risk difference outcomes patient receive receive anticoagulant antiplatelet therapy</brief_summary>
	<brief_title>Prospective Evaluation Bleeding Risk Anticoagulant Anti-platelet Therapy</brief_title>
	<detailed_description>1 . To evaluate bleeding risk interventional procedure patient without antiplatelet and/or anticoagulant therapy . 2 . To evaluate difference outcomes patient receive anticoagulant antiplatelet therapy compare patient receive various type drug anticoagulant antiplatelet therapeutic effect . 3 . To evaluate compare adverse event profile patient .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Anticoagulants</mesh_term>
	<criteria>Subjects undergoing interventional technique . Subjects able give voluntary , write informed consent . All thing , patient heparin , dextran , low molecular heparin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
</DOC>